Research reading
Medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale demand and the India (IND) to China (CHN) lane
China (CHN) reported $25.9M of medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail sale imports in 2022. India (IND) accounted for 0% of the observed market and reported $18.0 in exports on this lane.
The latest annual values eased slightly, while the longer available history shows +10.6% buyer growth and -33.2% exporter growth. The page separates reported values from projections and indicators.
